Mostrar el registro sencillo del ítem
Autor | Freitas, Luiz Antonio Rodrigues de | |
Autor | Mbow, M. Lamine | |
Autor | Estay, Monica | |
Autor | Bleyenberg, Julie A | |
Autor | Titus, Richard G | |
Fecha de acceso | 2014-07-10T12:30:06Z | |
Fecha de disponibilización | 2014-07-10T12:30:06Z | |
Fecha de publicación | 1999 | |
Referencia | FREITAS, L. A. R. et al. Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. Parasite Immunology, v. 21, n. 5, p. 273-277, 1999. | pt_BR |
ISSN | 0141-9838 | |
URI | https://www.arca.fiocruz.br/handle/icict/7900 | |
Idioma | eng | pt_BR |
Editor | Blackwell Science | pt_BR |
Derechos de autor | open access | pt_BR |
Título | Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania major. | pt_BR |
Tipo del documento | Article | pt_BR |
Resumen en Inglés | Prostaglandins of the E series inhibit the development of Th1 responses. When infected with Leishmania major, BALB/c mice fail to develop a Th1 response, but instead mount a Th2 response and die of the disease. Therefore, we treated L. major-infected BALB/c mice with indomethacin, which inhibits prostaglandin production. Indomethacin lessened disease severity (parasite burden and pathology), and promoted a Th1 response, but the mice still succumbed to infection. The explanation for these observations may be two-fold: (1) the beneficial effects of indomethacin were predominantly observed later in infection (beyond two weeks), a time at which indomethacin was unable to sufficiently block the development of a Th2 response; (2) indomethacin was unable to induce a Th1 response in BALB/c mice that was of the same magnitude as the Th1 response observed in C57BL/6 mice infected with L. major. | pt_BR |
Afiliación | Fundação Oswaldo Cruz. Centro de Pesquisa Gonçalo Moniz. Laboratório de Patologia e Biologia Celular. Salvador, BA, Brasil | pt_BR |
Afiliación | Colorado State University. Department of Pathology. College of Veterinary Medicine and Biomedical Sciences. Fort Collins, USA | pt_BR |
Afiliación | Colorado State University. Department of Pathology. College of Veterinary Medicine and Biomedical Sciences. Fort Collins, USA | pt_BR |
Afiliación | Colorado State University. Department of Pathology. College of Veterinary Medicine and Biomedical Sciences. Fort Collins, USA | pt_BR |
Afiliación | Colorado State University. Department of Pathology. College of Veterinary Medicine and Biomedical Sciences. Fort Collins, USA | pt_BR |
Palavras clave en Inglês | Leishmania major | pt_BR |
Palavras clave en Inglês | Leishmaniasis | pt_BR |
Palavras clave en Inglês | Prostaglandins | pt_BR |
Palavras clave en Inglês | Cytokines | pt_BR |
Palavras clave en Inglês | Nitric oxide | pt_BR |
DeCS | Antiprotozoários/uso terapêutico | pt_BR |
DeCS | Indometacina/uso terapêutico | pt_BR |
DeCS | Leishmania major | pt_BR |
DeCS | Leishmaniose Cutânea/quimioterapia | pt_BR |
DeCS | Células Th1/imunologia | pt_BR |
DeCS | Animais | pt_BR |
DeCS | Inibidores de Ciclo-Oxigenase/uso terapêutico | pt_BR |
DeCS | Progressão da Doença | pt_BR |
DeCS | Feminino | pt_BR |
DeCS | Imunidade Celular | pt_BR |
DeCS | Leishmaniose Cutânea/imunologia | pt_BR |
DeCS | Camundongos | pt_BR |
DeCS | Camundongos Endogâmicos BALB C | pt_BR |
DeCS | Antagonistas de Prostaglandina/uso terapêutico | pt_BR |